Melanoma Survivorship Management
Many important issues are relevant to melanoma survivors after initial melanoma diagnosis and treatment. A diagnosis of melanoma not only affects patients during the time of initial treatment, but also may play a significant role in their life for many years. These issues are broad and apply to many aspects of patients’ lives. This chapter will discuss overall and stage-specific surveillance strategies and methods for risk reduction and prevention that are important to the melanoma survivor population. It is also important for patients and care providers alike to understand and learn to manage sequelae that may accompany various melanoma treatments, from surgery to targeted therapies. Finally, this chapter will discuss issues relating to long-term survivorship such as psychosocial adjustment, reproductive issues, and health care costs.
KeywordsSentinel Lymph Node Biopsy BRAF Mutation Primary Melanoma BRAF Inhibitor Completion Lymph Node Dissection
- American Cancer Society. Cancer treatment and survivorship: facts and figures, 2012–2013. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-033876.pdf. Accessed September 27, 2013.
- American Cancer Society. Cancer facts & figures 2014. http://www.cancer.org/acs/groups/content/@research/documents/webcontent/acspc-042151.pdf. Accessed June 23, 2014.
- National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology—melanoma, v2.2013. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site. Accessed September 27, 2013.